VELCADE is a proteasome inhibitor indicated for treatment of patients with multiple myeloma and treatment of patients with mantle cell lymphoma who have received at least 1 prior therapy. VELCADE (Bortezomib) for Injection should be administered under the supervision of a qualified physician experienced in the uses of cancer chemotherapeutic agents.
Bortezomib, sold under the brand name Velcade among others, is an anti-cancer medication used to treat multiple myeloma and mantle cell lymphoma. This includes multiple myeloma in those who have and have not previously received treatment. It is generally used together with other medications. It is given by injection. Bortezomib was approved for medical use in the United States in 2003 and in Europe in 2004. It is on the World Health Organization's List of Essential Medicines, which lists the safest and most effective medicines needed in a health system.
Trade Name: VELCADE ® (bortezomib) for Injection. For subcutaneous or intravenous use
Generic Name: bortezomib
Single-use vial contains 3.5 mg of bortezomib as lyophilized powder.
For procurement cost of VELCADE (Bortezomib) brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 / 9891296838 or Email Us to know more details about the medicine and its cost price in India.
The order for VELCADE (Bortezomib) will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.
IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand VELCADE (Bortezomib) on prescription and Import License in Patient's Name only.
For overseas patients, VELCADE (Bortezomib) can be made available in Send your enquiry to find VELCADE (Bortezomib) in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.
For Velcade (Bortezomib) for injection Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details
Venclexta-Darzalex Combos Show Strong Response Rates in Multiple Myeloma Trial, Early Data Show For More Details
New Drug Benefits Patients With Myeloma Who Are Resistant to All Therapies For More Details